3622 results for «498»
3622 results
TAVI challenges: session 4
29 Nov 2022 – From PCR London Valves 2022
This PCR LV 2022 session includes no less than 8 cases of TAVI complications, including TAVR in iatrogenic acute native pure aortic regurgitation, TAVI in a young patient after orthotopic liver retransplantation, or percutaneous treatment of a subaortic membrane using a self-expandable TAVR.
TAVI complications: Session 4
29 Nov 2022 – From PCR London Valves 2022
With this selection of challenging cases, discover how to face various TAVI complications, such as: annular perforation, lost wire, aortoiliac rupture, bilateral coronary ostial occlusion, and much more!
Rapid-fire abstracts: Session 10
29 Nov 2022 – From PCR London Valves 2022
Discover a selection of abstracts presented during PCR LV 2022: trends in utilisation of percutaneous tricuspid valve vegetation debulking in endocarditis 2017-19, association of TRI-SCORE with clinical outcomes after transcatheter tricuspid valve repair, transcatheter edge-to-edge repair vs. percutaneous annuloplasty for tricuspid regurgitation, and more!
Rapid-fire clinical cases: Session 5
29 Nov 2022 – From PCR London Valves 2022
Discover a selection of cases submitted at PCR LV 2022 in this session: subacute thrombosis of a balloon-expandable aortic bioprosthesis, left axillary access for TAVI in a patient with two IMA grafts and a left side implanted pacemaker, avoiding paravalvular leak using computer simulation in bicuspid TAVI,...
Clinical outcomes after TAVI: Session 2
29 Nov 2022 – From PCR London Valves 2022
Consult this session on the clinical outcomes after TAVI to learn more about the first results after commercial TAVI utilising the JenaValve Trilogy system for aortic stenosis and aortic regurgitation, the outcomes of contrast-zero TAVI vs. standard practice in patients with severe renal dysfunction, and more!
Rapid-fire abstracts: Session 11
29 Nov 2022 – From PCR London Valves 2022
Discover a selection of abstracts presented during PCR LV 2022: the impact of cerebral embolic protection devices on acute ischaemic stroke complicating TAVI, TTVR clinical results prediction based on surgical risk scores, effects of tricuspid transcatheter edge-to-edge repair on tricuspid annular diameter, and much more!
TAVI in TAVI
29 Nov 2022 – From PCR London Valves 2022
Discover a selection of challenging cases in this session: valve-in-valve in a previous TAVR with healed endocarditis and aortic pseudoaneurysm closure, one-year SAPIEN 3 ultra failure treated with TAV-in-TAV with an Evolut Pro+ system, transcatheter valve implantation and coronary protection in a patient with prior valve-in-valve, and...
Rapid-fire clinical cases: Session 6
29 Nov 2022 – From PCR London Valves 2022
Discover a selection of abstracts presented during PCR LV 2022: valve-in-valve implant in a dysfunctional tricuspid bioprosthesis, first patient in TRICURE FIH trial, challenging percutaneous closure of prosthetic paravalvular leaks, and more!
Rapid-fire clinical cases: Session 7
29 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of abstracts presented during PCR LV 2022: simultaneous transcatheter edge-to-edge repair of mitral and tricuspid valve, transcatheter valve implantation in mitral and tricuspid valve position, TEER failure in mitral and tricuspid position: troubleshooting approach for a rare but still eventful case,...
Complex scenarios during mitral valve-in-valve, valve-in-ring or valve-in-MAC procedures - a case-based approach
29 Nov 2022 – From PCR London Valves 2022
Discover some complex scenarios during mitral valve-in-valve, valve-in-ring or valve-in-MAC procedures with these presentations, and learn more about the essential role of TOE and CT imaging in predicting procedural complexity, the pre-emptive techniques and strategies to avoid left ventricular outflow tract obstruction as well as the bailout emergency techniques when...
PCR Live from London: episode 5
29 Nov 2022 – From PCR London Valves 2022
Consult this episode 5 of PCR Live from London to discover a presentation regarding simulation lab sessions, and learn more about the possible complications in TEER and their management.
Mitral and tricuspid patients are different from the TAVI population - Impact on clinical care
28 Nov 2022 – From PCR London Valves 2022
Consult this session to learn more about the different needs of mitral and tricuspid patients, to appreciate what optimal medical therapy really means and to improve your knowledge of the anticoagulant requirements for different patient populations.
A patient-focused transcatheter portfolio of options to treat tricuspid regurgitation
19 May 2022 – From EuroPCR 2022
In this session from EuroPCR 2022, the speakers introduce different options available for treating tricuspid regurgitation. They discuss the anatomical considerations that define suitable candidates and review different transcatheter options and their key differentiators.
The conundrum of antithrombotic therapy in atrial fibrillation patients undergoing TAVI
19 May 2022 – From EuroPCR 2022
Consult this session to learn more about the characteristics of atrial fibrillation patients undergoing TAVI, the priority of stroke prevention in atrial fibrillation patients post-TAVI, as well as the current understanding in Japanese and Asian patients.
Mitral replacement: expanding patient options, even mitral annular calcification!
18 May 2022 – From EUROPCR 2022
The objectives of this session from EuroPCR 2022 are to provide the best pathway for mitral regurgitation management, to learn about early commercial TMVR experience and to discover treatment options for mitral annular calcification patients.
The challenge of the diabetic patient with diffuse coronary artery disease: how physiology can simplify things
18 May 2022 – From EuroPCR 2022
Based on the didactic analysis of several practical cases, and also on the latest guidelines and study outcomes on the subject, learn in this EuroPCR 2022 session new management strategies to optimise PCI in diffuse coronary artery disease, new developments of the Optowire to support decision-making in patients...
Angiography-derived physiological assessment of coronary artery stenosis severity and microvascular dysfunctions
18 May 2022 – From EuroPCR 2022
Follow the demonstrations of this EuroPCR 2022 session to understand the principles, clinical value, and applicability of coronary angiography-derived fractional flow reserve (caFFR), to discuss coronary angiography-derived index of microcirculatory resistance (caIMR) in the assessment of epicardial stenosis and coronary microcirculation, and to review data from available trials supporting these new...
Simplifying complex coronary interventions by adopting angiography-based physiology and a healing-targeted DES
19 May 2022 – From EuroPCR 2022
Consult this session to learn how to apply angio-based physiology to optimise patient selection for PCI, to discuss the impact of a healing-targeted DES on outcomes and DAPT duration, as well as to learn about the HT Supreme DES implantations in the (ongoing) QFR-guided, PIONEER IV trial.
State-of-the-art imaging for structural heart disease interventions
19 May 2022 – From EuroPCR 2022
This EuroPCR 2022 session aims to focus on imaging and help understand what imaging has changed in recent years: learn how to perform pre-procedural planning and how advanced imaging can make procedures easier and safer.
Nothing to fear - a guide to combine DCB and DES in hybrid PCI
19 May 2022 – From EuroPCR 2022
DCB in in-stent restenosis, DCB and DES, DCB in ACS, and a guide to use DCB in de novo lesions and bifurcations: this is the programme of this EuroPCR 2022 session devoted, not surprisingly, to drug-coated balloons.
